News

  • 15 November 2017

    Seres to study microbiome therapy for immuno-oncology

    Seres Therapeutics has partnered with the University of Texas' MD Anderson Cancer Centre and Parker Institute for Cancer Immunotherapy to conduct a clinical study of microbiome therapy in patients with...